0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global COVID-19 Diagnostic Kits Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-35N11239
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global COVID 19 Diagnostic Kits Market Research Report 2022
BUY CHAPTERS

Global COVID-19 Diagnostic Kits Market Research Report 2025

Code: QYRE-Auto-35N11239
Report
March 2025
Pages:115
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

COVID-19 Diagnostic Kits Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

COVID-19 Diagnostic Kits Market

COVID-19 Diagnostic Kits Market

The global market for COVID-19 Diagnostic Kits was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Coronavirus disease 2019 (COVID-19) is an infectious acute respiratory disease caused by a novel coronavirus. There are different types of COVID-19 tests - diagnostic tests and antibody tests. COVID-19 testing includes molecular testing, antigen testing, and antibody testing. Samples for COVID-19 diagnostic tests are usually collected using an anterior nasal (nose) swab sample. Some diagnostic tests use a sample of the middle turbinate, nasopharynx, oropharynx, or saliva.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for COVID-19 Diagnostic Kits, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding COVID-19 Diagnostic Kits.
The COVID-19 Diagnostic Kits market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global COVID-19 Diagnostic Kits market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the COVID-19 Diagnostic Kits manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of COVID-19 Diagnostic Kits Market Report

Report Metric Details
Report Name COVID-19 Diagnostic Kits Market
CAGR 5%
Segment by Type
Segment by Application
  • Hospital
  • Laboratory
  • Home
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Abbott, Access Bio, ACON Laboratories, Alveo Technologies, Applied BioCode, ARISTA Biotech, BD, Biocartis, BioFire Diagnostics, BioMedomics, Cepheid, Co-Diagnostics, Cue Health, Diasorin, Ellume, Grifols, Hologic, Andon Health, Lepu Medical, Lucira Health, Orient Gene, Quidel, Roche, Shenzhen YHLO Biotech, Guangzhou Wondfo Biotech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of COVID-19 Diagnostic Kits manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of COVID-19 Diagnostic Kits in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the COVID-19 Diagnostic Kits Market report?

Ans: The main players in the COVID-19 Diagnostic Kits Market are Abbott, Access Bio, ACON Laboratories, Alveo Technologies, Applied BioCode, ARISTA Biotech, BD, Biocartis, BioFire Diagnostics, BioMedomics, Cepheid, Co-Diagnostics, Cue Health, Diasorin, Ellume, Grifols, Hologic, Andon Health, Lepu Medical, Lucira Health, Orient Gene, Quidel, Roche, Shenzhen YHLO Biotech, Guangzhou Wondfo Biotech

What are the Application segmentation covered in the COVID-19 Diagnostic Kits Market report?

Ans: The Applications covered in the COVID-19 Diagnostic Kits Market report are Hospital, Laboratory, Home

What are the Type segmentation covered in the COVID-19 Diagnostic Kits Market report?

Ans: The Types covered in the COVID-19 Diagnostic Kits Market report are Molecular Detection, Antigen Detection, Antibody Detection

Recommended Reports

COVID-19 Diagnostics

COVID-19 Therapeutics

COVID-19 Vaccines

1 COVID-19 Diagnostic Kits Market Overview
1.1 Product Definition
1.2 COVID-19 Diagnostic Kits by Type
1.2.1 Global COVID-19 Diagnostic Kits Market Value Comparison by Type (2024 VS 2031)
1.2.2 Molecular Detection
1.2.3 Antigen Detection
1.2.4 Antibody Detection
1.3 COVID-19 Diagnostic Kits by Application
1.3.1 Global COVID-19 Diagnostic Kits Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Laboratory
1.3.4 Home
1.4 Global COVID-19 Diagnostic Kits Market Size Estimates and Forecasts
1.4.1 Global COVID-19 Diagnostic Kits Revenue 2020-2031
1.4.2 Global COVID-19 Diagnostic Kits Sales 2020-2031
1.4.3 Global COVID-19 Diagnostic Kits Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 COVID-19 Diagnostic Kits Market Competition by Manufacturers
2.1 Global COVID-19 Diagnostic Kits Sales Market Share by Manufacturers (2020-2025)
2.2 Global COVID-19 Diagnostic Kits Revenue Market Share by Manufacturers (2020-2025)
2.3 Global COVID-19 Diagnostic Kits Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of COVID-19 Diagnostic Kits, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of COVID-19 Diagnostic Kits, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of COVID-19 Diagnostic Kits, Product Type & Application
2.7 Global Key Manufacturers of COVID-19 Diagnostic Kits, Date of Enter into This Industry
2.8 Global COVID-19 Diagnostic Kits Market Competitive Situation and Trends
2.8.1 Global COVID-19 Diagnostic Kits Market Concentration Rate
2.8.2 The Global 5 and 10 Largest COVID-19 Diagnostic Kits Players Market Share by Revenue
2.8.3 Global COVID-19 Diagnostic Kits Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global COVID-19 Diagnostic Kits Market Scenario by Region
3.1 Global COVID-19 Diagnostic Kits Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global COVID-19 Diagnostic Kits Sales by Region: 2020-2031
3.2.1 Global COVID-19 Diagnostic Kits Sales by Region: 2020-2025
3.2.2 Global COVID-19 Diagnostic Kits Sales by Region: 2026-2031
3.3 Global COVID-19 Diagnostic Kits Revenue by Region: 2020-2031
3.3.1 Global COVID-19 Diagnostic Kits Revenue by Region: 2020-2025
3.3.2 Global COVID-19 Diagnostic Kits Revenue by Region: 2026-2031
3.4 North America COVID-19 Diagnostic Kits Market Facts & Figures by Country
3.4.1 North America COVID-19 Diagnostic Kits Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America COVID-19 Diagnostic Kits Sales by Country (2020-2031)
3.4.3 North America COVID-19 Diagnostic Kits Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe COVID-19 Diagnostic Kits Market Facts & Figures by Country
3.5.1 Europe COVID-19 Diagnostic Kits Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe COVID-19 Diagnostic Kits Sales by Country (2020-2031)
3.5.3 Europe COVID-19 Diagnostic Kits Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific COVID-19 Diagnostic Kits Market Facts & Figures by Region
3.6.1 Asia Pacific COVID-19 Diagnostic Kits Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific COVID-19 Diagnostic Kits Sales by Region (2020-2031)
3.6.3 Asia Pacific COVID-19 Diagnostic Kits Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America COVID-19 Diagnostic Kits Market Facts & Figures by Country
3.7.1 Latin America COVID-19 Diagnostic Kits Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America COVID-19 Diagnostic Kits Sales by Country (2020-2031)
3.7.3 Latin America COVID-19 Diagnostic Kits Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa COVID-19 Diagnostic Kits Market Facts & Figures by Country
3.8.1 Middle East and Africa COVID-19 Diagnostic Kits Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa COVID-19 Diagnostic Kits Sales by Country (2020-2031)
3.8.3 Middle East and Africa COVID-19 Diagnostic Kits Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global COVID-19 Diagnostic Kits Sales by Type (2020-2031)
4.1.1 Global COVID-19 Diagnostic Kits Sales by Type (2020-2025)
4.1.2 Global COVID-19 Diagnostic Kits Sales by Type (2026-2031)
4.1.3 Global COVID-19 Diagnostic Kits Sales Market Share by Type (2020-2031)
4.2 Global COVID-19 Diagnostic Kits Revenue by Type (2020-2031)
4.2.1 Global COVID-19 Diagnostic Kits Revenue by Type (2020-2025)
4.2.2 Global COVID-19 Diagnostic Kits Revenue by Type (2026-2031)
4.2.3 Global COVID-19 Diagnostic Kits Revenue Market Share by Type (2020-2031)
4.3 Global COVID-19 Diagnostic Kits Price by Type (2020-2031)
5 Segment by Application
5.1 Global COVID-19 Diagnostic Kits Sales by Application (2020-2031)
5.1.1 Global COVID-19 Diagnostic Kits Sales by Application (2020-2025)
5.1.2 Global COVID-19 Diagnostic Kits Sales by Application (2026-2031)
5.1.3 Global COVID-19 Diagnostic Kits Sales Market Share by Application (2020-2031)
5.2 Global COVID-19 Diagnostic Kits Revenue by Application (2020-2031)
5.2.1 Global COVID-19 Diagnostic Kits Revenue by Application (2020-2025)
5.2.2 Global COVID-19 Diagnostic Kits Revenue by Application (2026-2031)
5.2.3 Global COVID-19 Diagnostic Kits Revenue Market Share by Application (2020-2031)
5.3 Global COVID-19 Diagnostic Kits Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Company Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott COVID-19 Diagnostic Kits Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Abbott COVID-19 Diagnostic Kits Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Access Bio
6.2.1 Access Bio Company Information
6.2.2 Access Bio Description and Business Overview
6.2.3 Access Bio COVID-19 Diagnostic Kits Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Access Bio COVID-19 Diagnostic Kits Product Portfolio
6.2.5 Access Bio Recent Developments/Updates
6.3 ACON Laboratories
6.3.1 ACON Laboratories Company Information
6.3.2 ACON Laboratories Description and Business Overview
6.3.3 ACON Laboratories COVID-19 Diagnostic Kits Sales, Revenue and Gross Margin (2020-2025)
6.3.4 ACON Laboratories COVID-19 Diagnostic Kits Product Portfolio
6.3.5 ACON Laboratories Recent Developments/Updates
6.4 Alveo Technologies
6.4.1 Alveo Technologies Company Information
6.4.2 Alveo Technologies Description and Business Overview
6.4.3 Alveo Technologies COVID-19 Diagnostic Kits Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Alveo Technologies COVID-19 Diagnostic Kits Product Portfolio
6.4.5 Alveo Technologies Recent Developments/Updates
6.5 Applied BioCode
6.5.1 Applied BioCode Company Information
6.5.2 Applied BioCode Description and Business Overview
6.5.3 Applied BioCode COVID-19 Diagnostic Kits Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Applied BioCode COVID-19 Diagnostic Kits Product Portfolio
6.5.5 Applied BioCode Recent Developments/Updates
6.6 ARISTA Biotech
6.6.1 ARISTA Biotech Company Information
6.6.2 ARISTA Biotech Description and Business Overview
6.6.3 ARISTA Biotech COVID-19 Diagnostic Kits Sales, Revenue and Gross Margin (2020-2025)
6.6.4 ARISTA Biotech COVID-19 Diagnostic Kits Product Portfolio
6.6.5 ARISTA Biotech Recent Developments/Updates
6.7 BD
6.7.1 BD Company Information
6.7.2 BD Description and Business Overview
6.7.3 BD COVID-19 Diagnostic Kits Sales, Revenue and Gross Margin (2020-2025)
6.7.4 BD COVID-19 Diagnostic Kits Product Portfolio
6.7.5 BD Recent Developments/Updates
6.8 Biocartis
6.8.1 Biocartis Company Information
6.8.2 Biocartis Description and Business Overview
6.8.3 Biocartis COVID-19 Diagnostic Kits Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Biocartis COVID-19 Diagnostic Kits Product Portfolio
6.8.5 Biocartis Recent Developments/Updates
6.9 BioFire Diagnostics
6.9.1 BioFire Diagnostics Company Information
6.9.2 BioFire Diagnostics Description and Business Overview
6.9.3 BioFire Diagnostics COVID-19 Diagnostic Kits Sales, Revenue and Gross Margin (2020-2025)
6.9.4 BioFire Diagnostics COVID-19 Diagnostic Kits Product Portfolio
6.9.5 BioFire Diagnostics Recent Developments/Updates
6.10 BioMedomics
6.10.1 BioMedomics Company Information
6.10.2 BioMedomics Description and Business Overview
6.10.3 BioMedomics COVID-19 Diagnostic Kits Sales, Revenue and Gross Margin (2020-2025)
6.10.4 BioMedomics COVID-19 Diagnostic Kits Product Portfolio
6.10.5 BioMedomics Recent Developments/Updates
6.11 Cepheid
6.11.1 Cepheid Company Information
6.11.2 Cepheid Description and Business Overview
6.11.3 Cepheid COVID-19 Diagnostic Kits Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Cepheid COVID-19 Diagnostic Kits Product Portfolio
6.11.5 Cepheid Recent Developments/Updates
6.12 Co-Diagnostics
6.12.1 Co-Diagnostics Company Information
6.12.2 Co-Diagnostics Description and Business Overview
6.12.3 Co-Diagnostics COVID-19 Diagnostic Kits Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Co-Diagnostics COVID-19 Diagnostic Kits Product Portfolio
6.12.5 Co-Diagnostics Recent Developments/Updates
6.13 Cue Health
6.13.1 Cue Health Company Information
6.13.2 Cue Health Description and Business Overview
6.13.3 Cue Health COVID-19 Diagnostic Kits Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Cue Health COVID-19 Diagnostic Kits Product Portfolio
6.13.5 Cue Health Recent Developments/Updates
6.14 Diasorin
6.14.1 Diasorin Company Information
6.14.2 Diasorin Description and Business Overview
6.14.3 Diasorin COVID-19 Diagnostic Kits Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Diasorin COVID-19 Diagnostic Kits Product Portfolio
6.14.5 Diasorin Recent Developments/Updates
6.15 Ellume
6.15.1 Ellume Company Information
6.15.2 Ellume Description and Business Overview
6.15.3 Ellume COVID-19 Diagnostic Kits Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Ellume COVID-19 Diagnostic Kits Product Portfolio
6.15.5 Ellume Recent Developments/Updates
6.16 Grifols
6.16.1 Grifols Company Information
6.16.2 Grifols Description and Business Overview
6.16.3 Grifols COVID-19 Diagnostic Kits Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Grifols COVID-19 Diagnostic Kits Product Portfolio
6.16.5 Grifols Recent Developments/Updates
6.17 Hologic
6.17.1 Hologic Company Information
6.17.2 Hologic Description and Business Overview
6.17.3 Hologic COVID-19 Diagnostic Kits Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Hologic COVID-19 Diagnostic Kits Product Portfolio
6.17.5 Hologic Recent Developments/Updates
6.18 Andon Health
6.18.1 Andon Health Company Information
6.18.2 Andon Health Description and Business Overview
6.18.3 Andon Health COVID-19 Diagnostic Kits Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Andon Health COVID-19 Diagnostic Kits Product Portfolio
6.18.5 Andon Health Recent Developments/Updates
6.19 Lepu Medical
6.19.1 Lepu Medical Company Information
6.19.2 Lepu Medical Description and Business Overview
6.19.3 Lepu Medical COVID-19 Diagnostic Kits Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Lepu Medical COVID-19 Diagnostic Kits Product Portfolio
6.19.5 Lepu Medical Recent Developments/Updates
6.20 Lucira Health
6.20.1 Lucira Health Company Information
6.20.2 Lucira Health Description and Business Overview
6.20.3 Lucira Health COVID-19 Diagnostic Kits Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Lucira Health COVID-19 Diagnostic Kits Product Portfolio
6.20.5 Lucira Health Recent Developments/Updates
6.21 Orient Gene
6.21.1 Orient Gene Company Information
6.21.2 Orient Gene Description and Business Overview
6.21.3 Orient Gene COVID-19 Diagnostic Kits Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Orient Gene COVID-19 Diagnostic Kits Product Portfolio
6.21.5 Orient Gene Recent Developments/Updates
6.22 Quidel
6.22.1 Quidel Company Information
6.22.2 Quidel Description and Business Overview
6.22.3 Quidel COVID-19 Diagnostic Kits Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Quidel COVID-19 Diagnostic Kits Product Portfolio
6.22.5 Quidel Recent Developments/Updates
6.23 Roche
6.23.1 Roche Company Information
6.23.2 Roche Description and Business Overview
6.23.3 Roche COVID-19 Diagnostic Kits Sales, Revenue and Gross Margin (2020-2025)
6.23.4 Roche COVID-19 Diagnostic Kits Product Portfolio
6.23.5 Roche Recent Developments/Updates
6.24 Shenzhen YHLO Biotech
6.24.1 Shenzhen YHLO Biotech Company Information
6.24.2 Shenzhen YHLO Biotech Description and Business Overview
6.24.3 Shenzhen YHLO Biotech COVID-19 Diagnostic Kits Sales, Revenue and Gross Margin (2020-2025)
6.24.4 Shenzhen YHLO Biotech COVID-19 Diagnostic Kits Product Portfolio
6.24.5 Shenzhen YHLO Biotech Recent Developments/Updates
6.25 Guangzhou Wondfo Biotech
6.25.1 Guangzhou Wondfo Biotech Company Information
6.25.2 Guangzhou Wondfo Biotech Description and Business Overview
6.25.3 Guangzhou Wondfo Biotech COVID-19 Diagnostic Kits Sales, Revenue and Gross Margin (2020-2025)
6.25.4 Guangzhou Wondfo Biotech COVID-19 Diagnostic Kits Product Portfolio
6.25.5 Guangzhou Wondfo Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 COVID-19 Diagnostic Kits Industry Chain Analysis
7.2 COVID-19 Diagnostic Kits Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 COVID-19 Diagnostic Kits Production Mode & Process Analysis
7.4 COVID-19 Diagnostic Kits Sales and Marketing
7.4.1 COVID-19 Diagnostic Kits Sales Channels
7.4.2 COVID-19 Diagnostic Kits Distributors
7.5 COVID-19 Diagnostic Kits Customer Analysis
8 COVID-19 Diagnostic Kits Market Dynamics
8.1 COVID-19 Diagnostic Kits Industry Trends
8.2 COVID-19 Diagnostic Kits Market Drivers
8.3 COVID-19 Diagnostic Kits Market Challenges
8.4 COVID-19 Diagnostic Kits Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global COVID-19 Diagnostic Kits Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global COVID-19 Diagnostic Kits Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global COVID-19 Diagnostic Kits Market Competitive Situation by Manufacturers in 2024
 Table 4. Global COVID-19 Diagnostic Kits Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global COVID-19 Diagnostic Kits Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global COVID-19 Diagnostic Kits Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global COVID-19 Diagnostic Kits Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market COVID-19 Diagnostic Kits Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of COVID-19 Diagnostic Kits, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of COVID-19 Diagnostic Kits, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of COVID-19 Diagnostic Kits, Product Type & Application
 Table 12. Global Key Manufacturers of COVID-19 Diagnostic Kits, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global COVID-19 Diagnostic Kits by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 Diagnostic Kits as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global COVID-19 Diagnostic Kits Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global COVID-19 Diagnostic Kits Sales by Region (2020-2025) & (K Units)
 Table 18. Global COVID-19 Diagnostic Kits Sales Market Share by Region (2020-2025)
 Table 19. Global COVID-19 Diagnostic Kits Sales by Region (2026-2031) & (K Units)
 Table 20. Global COVID-19 Diagnostic Kits Sales Market Share by Region (2026-2031)
 Table 21. Global COVID-19 Diagnostic Kits Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global COVID-19 Diagnostic Kits Revenue Market Share by Region (2020-2025)
 Table 23. Global COVID-19 Diagnostic Kits Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global COVID-19 Diagnostic Kits Revenue Market Share by Region (2026-2031)
 Table 25. North America COVID-19 Diagnostic Kits Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America COVID-19 Diagnostic Kits Sales by Country (2020-2025) & (K Units)
 Table 27. North America COVID-19 Diagnostic Kits Sales by Country (2026-2031) & (K Units)
 Table 28. North America COVID-19 Diagnostic Kits Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America COVID-19 Diagnostic Kits Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe COVID-19 Diagnostic Kits Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe COVID-19 Diagnostic Kits Sales by Country (2020-2025) & (K Units)
 Table 32. Europe COVID-19 Diagnostic Kits Sales by Country (2026-2031) & (K Units)
 Table 33. Europe COVID-19 Diagnostic Kits Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe COVID-19 Diagnostic Kits Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific COVID-19 Diagnostic Kits Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific COVID-19 Diagnostic Kits Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific COVID-19 Diagnostic Kits Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific COVID-19 Diagnostic Kits Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific COVID-19 Diagnostic Kits Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America COVID-19 Diagnostic Kits Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America COVID-19 Diagnostic Kits Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America COVID-19 Diagnostic Kits Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America COVID-19 Diagnostic Kits Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America COVID-19 Diagnostic Kits Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa COVID-19 Diagnostic Kits Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa COVID-19 Diagnostic Kits Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa COVID-19 Diagnostic Kits Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa COVID-19 Diagnostic Kits Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa COVID-19 Diagnostic Kits Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global COVID-19 Diagnostic Kits Sales (K Units) by Type (2020-2025)
 Table 51. Global COVID-19 Diagnostic Kits Sales (K Units) by Type (2026-2031)
 Table 52. Global COVID-19 Diagnostic Kits Sales Market Share by Type (2020-2025)
 Table 53. Global COVID-19 Diagnostic Kits Sales Market Share by Type (2026-2031)
 Table 54. Global COVID-19 Diagnostic Kits Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global COVID-19 Diagnostic Kits Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global COVID-19 Diagnostic Kits Revenue Market Share by Type (2020-2025)
 Table 57. Global COVID-19 Diagnostic Kits Revenue Market Share by Type (2026-2031)
 Table 58. Global COVID-19 Diagnostic Kits Price (US$/Unit) by Type (2020-2025)
 Table 59. Global COVID-19 Diagnostic Kits Price (US$/Unit) by Type (2026-2031)
 Table 60. Global COVID-19 Diagnostic Kits Sales (K Units) by Application (2020-2025)
 Table 61. Global COVID-19 Diagnostic Kits Sales (K Units) by Application (2026-2031)
 Table 62. Global COVID-19 Diagnostic Kits Sales Market Share by Application (2020-2025)
 Table 63. Global COVID-19 Diagnostic Kits Sales Market Share by Application (2026-2031)
 Table 64. Global COVID-19 Diagnostic Kits Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global COVID-19 Diagnostic Kits Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global COVID-19 Diagnostic Kits Revenue Market Share by Application (2020-2025)
 Table 67. Global COVID-19 Diagnostic Kits Revenue Market Share by Application (2026-2031)
 Table 68. Global COVID-19 Diagnostic Kits Price (US$/Unit) by Application (2020-2025)
 Table 69. Global COVID-19 Diagnostic Kits Price (US$/Unit) by Application (2026-2031)
 Table 70. Abbott Company Information
 Table 71. Abbott Description and Business Overview
 Table 72. Abbott COVID-19 Diagnostic Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Abbott COVID-19 Diagnostic Kits Product
 Table 74. Abbott Recent Developments/Updates
 Table 75. Access Bio Company Information
 Table 76. Access Bio Description and Business Overview
 Table 77. Access Bio COVID-19 Diagnostic Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Access Bio COVID-19 Diagnostic Kits Product
 Table 79. Access Bio Recent Developments/Updates
 Table 80. ACON Laboratories Company Information
 Table 81. ACON Laboratories Description and Business Overview
 Table 82. ACON Laboratories COVID-19 Diagnostic Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. ACON Laboratories COVID-19 Diagnostic Kits Product
 Table 84. ACON Laboratories Recent Developments/Updates
 Table 85. Alveo Technologies Company Information
 Table 86. Alveo Technologies Description and Business Overview
 Table 87. Alveo Technologies COVID-19 Diagnostic Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Alveo Technologies COVID-19 Diagnostic Kits Product
 Table 89. Alveo Technologies Recent Developments/Updates
 Table 90. Applied BioCode Company Information
 Table 91. Applied BioCode Description and Business Overview
 Table 92. Applied BioCode COVID-19 Diagnostic Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Applied BioCode COVID-19 Diagnostic Kits Product
 Table 94. Applied BioCode Recent Developments/Updates
 Table 95. ARISTA Biotech Company Information
 Table 96. ARISTA Biotech Description and Business Overview
 Table 97. ARISTA Biotech COVID-19 Diagnostic Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. ARISTA Biotech COVID-19 Diagnostic Kits Product
 Table 99. ARISTA Biotech Recent Developments/Updates
 Table 100. BD Company Information
 Table 101. BD Description and Business Overview
 Table 102. BD COVID-19 Diagnostic Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. BD COVID-19 Diagnostic Kits Product
 Table 104. BD Recent Developments/Updates
 Table 105. Biocartis Company Information
 Table 106. Biocartis Description and Business Overview
 Table 107. Biocartis COVID-19 Diagnostic Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Biocartis COVID-19 Diagnostic Kits Product
 Table 109. Biocartis Recent Developments/Updates
 Table 110. BioFire Diagnostics Company Information
 Table 111. BioFire Diagnostics Description and Business Overview
 Table 112. BioFire Diagnostics COVID-19 Diagnostic Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. BioFire Diagnostics COVID-19 Diagnostic Kits Product
 Table 114. BioFire Diagnostics Recent Developments/Updates
 Table 115. BioMedomics Company Information
 Table 116. BioMedomics Description and Business Overview
 Table 117. BioMedomics COVID-19 Diagnostic Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. BioMedomics COVID-19 Diagnostic Kits Product
 Table 119. BioMedomics Recent Developments/Updates
 Table 120. Cepheid Company Information
 Table 121. Cepheid Description and Business Overview
 Table 122. Cepheid COVID-19 Diagnostic Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Cepheid COVID-19 Diagnostic Kits Product
 Table 124. Cepheid Recent Developments/Updates
 Table 125. Co-Diagnostics Company Information
 Table 126. Co-Diagnostics Description and Business Overview
 Table 127. Co-Diagnostics COVID-19 Diagnostic Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Co-Diagnostics COVID-19 Diagnostic Kits Product
 Table 129. Co-Diagnostics Recent Developments/Updates
 Table 130. Cue Health Company Information
 Table 131. Cue Health Description and Business Overview
 Table 132. Cue Health COVID-19 Diagnostic Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Cue Health COVID-19 Diagnostic Kits Product
 Table 134. Cue Health Recent Developments/Updates
 Table 135. Diasorin Company Information
 Table 136. Diasorin Description and Business Overview
 Table 137. Diasorin COVID-19 Diagnostic Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Diasorin COVID-19 Diagnostic Kits Product
 Table 139. Diasorin Recent Developments/Updates
 Table 140. Ellume Company Information
 Table 141. Ellume Description and Business Overview
 Table 142. Ellume COVID-19 Diagnostic Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Ellume COVID-19 Diagnostic Kits Product
 Table 144. Ellume Recent Developments/Updates
 Table 145. Grifols Company Information
 Table 146. Grifols Description and Business Overview
 Table 147. Grifols COVID-19 Diagnostic Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Grifols COVID-19 Diagnostic Kits Product
 Table 149. Grifols Recent Developments/Updates
 Table 150. Hologic Company Information
 Table 151. Hologic Description and Business Overview
 Table 152. Hologic COVID-19 Diagnostic Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Hologic COVID-19 Diagnostic Kits Product
 Table 154. Hologic Recent Developments/Updates
 Table 155. Andon Health Company Information
 Table 156. Andon Health Description and Business Overview
 Table 157. Andon Health COVID-19 Diagnostic Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Andon Health COVID-19 Diagnostic Kits Product
 Table 159. Andon Health Recent Developments/Updates
 Table 160. Lepu Medical Company Information
 Table 161. Lepu Medical Description and Business Overview
 Table 162. Lepu Medical COVID-19 Diagnostic Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. Lepu Medical COVID-19 Diagnostic Kits Product
 Table 164. Lepu Medical Recent Developments/Updates
 Table 165. Lucira Health Company Information
 Table 166. Lucira Health Description and Business Overview
 Table 167. Lucira Health COVID-19 Diagnostic Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 168. Lucira Health COVID-19 Diagnostic Kits Product
 Table 169. Lucira Health Recent Developments/Updates
 Table 170. Orient Gene Company Information
 Table 171. Orient Gene Description and Business Overview
 Table 172. Orient Gene COVID-19 Diagnostic Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 173. Orient Gene COVID-19 Diagnostic Kits Product
 Table 174. Orient Gene Recent Developments/Updates
 Table 175. Quidel Company Information
 Table 176. Quidel Description and Business Overview
 Table 177. Quidel COVID-19 Diagnostic Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 178. Quidel COVID-19 Diagnostic Kits Product
 Table 179. Quidel Recent Developments/Updates
 Table 180. Roche Company Information
 Table 181. Roche Description and Business Overview
 Table 182. Roche COVID-19 Diagnostic Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 183. Roche COVID-19 Diagnostic Kits Product
 Table 184. Roche Recent Developments/Updates
 Table 185. Shenzhen YHLO Biotech Company Information
 Table 186. Shenzhen YHLO Biotech Description and Business Overview
 Table 187. Shenzhen YHLO Biotech COVID-19 Diagnostic Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 188. Shenzhen YHLO Biotech COVID-19 Diagnostic Kits Product
 Table 189. Shenzhen YHLO Biotech Recent Developments/Updates
 Table 190. Guangzhou Wondfo Biotech Company Information
 Table 191. Guangzhou Wondfo Biotech Description and Business Overview
 Table 192. Guangzhou Wondfo Biotech COVID-19 Diagnostic Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 193. Guangzhou Wondfo Biotech COVID-19 Diagnostic Kits Product
 Table 194. Guangzhou Wondfo Biotech Recent Developments/Updates
 Table 195. Key Raw Materials Lists
 Table 196. Raw Materials Key Suppliers Lists
 Table 197. COVID-19 Diagnostic Kits Distributors List
 Table 198. COVID-19 Diagnostic Kits Customers List
 Table 199. COVID-19 Diagnostic Kits Market Trends
 Table 200. COVID-19 Diagnostic Kits Market Drivers
 Table 201. COVID-19 Diagnostic Kits Market Challenges
 Table 202. COVID-19 Diagnostic Kits Market Restraints
 Table 203. Research Programs/Design for This Report
 Table 204. Key Data Information from Secondary Sources
 Table 205. Key Data Information from Primary Sources
 Table 206. Authors List of This Report


List of Figures
 Figure 1. Product Picture of COVID-19 Diagnostic Kits
 Figure 2. Global COVID-19 Diagnostic Kits Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global COVID-19 Diagnostic Kits Market Share by Type: 2024 & 2031
 Figure 4. Molecular Detection Product Picture
 Figure 5. Antigen Detection Product Picture
 Figure 6. Antibody Detection Product Picture
 Figure 7. Global COVID-19 Diagnostic Kits Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global COVID-19 Diagnostic Kits Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Laboratory
 Figure 11. Home
 Figure 12. Global COVID-19 Diagnostic Kits Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global COVID-19 Diagnostic Kits Market Size (2020-2031) & (US$ Million)
 Figure 14. Global COVID-19 Diagnostic Kits Sales (2020-2031) & (K Units)
 Figure 15. Global COVID-19 Diagnostic Kits Average Price (US$/Unit) & (2020-2031)
 Figure 16. COVID-19 Diagnostic Kits Report Years Considered
 Figure 17. COVID-19 Diagnostic Kits Sales Share by Manufacturers in 2024
 Figure 18. Global COVID-19 Diagnostic Kits Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest COVID-19 Diagnostic Kits Players: Market Share by Revenue in COVID-19 Diagnostic Kits in 2024
 Figure 20. COVID-19 Diagnostic Kits Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global COVID-19 Diagnostic Kits Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America COVID-19 Diagnostic Kits Sales Market Share by Country (2020-2031)
 Figure 23. North America COVID-19 Diagnostic Kits Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. COVID-19 Diagnostic Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada COVID-19 Diagnostic Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe COVID-19 Diagnostic Kits Sales Market Share by Country (2020-2031)
 Figure 27. Europe COVID-19 Diagnostic Kits Revenue Market Share by Country (2020-2031)
 Figure 28. Germany COVID-19 Diagnostic Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France COVID-19 Diagnostic Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. COVID-19 Diagnostic Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy COVID-19 Diagnostic Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia COVID-19 Diagnostic Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific COVID-19 Diagnostic Kits Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific COVID-19 Diagnostic Kits Revenue Market Share by Region (2020-2031)
 Figure 35. China COVID-19 Diagnostic Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan COVID-19 Diagnostic Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea COVID-19 Diagnostic Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India COVID-19 Diagnostic Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia COVID-19 Diagnostic Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan COVID-19 Diagnostic Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia COVID-19 Diagnostic Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand COVID-19 Diagnostic Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia COVID-19 Diagnostic Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines COVID-19 Diagnostic Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America COVID-19 Diagnostic Kits Sales Market Share by Country (2020-2031)
 Figure 46. Latin America COVID-19 Diagnostic Kits Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico COVID-19 Diagnostic Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil COVID-19 Diagnostic Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina COVID-19 Diagnostic Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa COVID-19 Diagnostic Kits Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa COVID-19 Diagnostic Kits Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey COVID-19 Diagnostic Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia COVID-19 Diagnostic Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. U.A.E COVID-19 Diagnostic Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of COVID-19 Diagnostic Kits by Type (2020-2031)
 Figure 56. Global Revenue Market Share of COVID-19 Diagnostic Kits by Type (2020-2031)
 Figure 57. Global COVID-19 Diagnostic Kits Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of COVID-19 Diagnostic Kits by Application (2020-2031)
 Figure 59. Global Revenue Market Share of COVID-19 Diagnostic Kits by Application (2020-2031)
 Figure 60. Global COVID-19 Diagnostic Kits Price (US$/Unit) by Application (2020-2031)
 Figure 61. COVID-19 Diagnostic Kits Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network